NASDAQ: IDEX - Ideanomics Capitalizing on the Electric

New Post Public Reply Private Reply Replies (0) Message Board
Goreman
208
NASDAQ: IDEX - Ideanomics

Capitalizing on the Electric Vehicle Revolution

"Focused on facilitating end-to-end solutions for the purchase of commercial electric vehicles & developing next generation of financial services and Fintech products"


Key Investment Highlights


• EV World Market Growth CAGR of 25.6%
• Institutional Ownership
• Stock Trades Below Book Value
• Doing Business In the Largest Market in the World
• Strong Experienced Management
• 2020 Exponential Growth


Overview

Ideanomics, Inc. trades on the Nasdaq under the symbol IDEX is based in New York, NY, USA, and has offices in Beijing, China.

Ideanomics is a diversified company and primarily operates in the United States and Asia with reported assets of $164,763,676 along with revenues of $ 43,286,378 (Q-3 2019).

Its main operating division is the Mobile Energy Group (MEG) which has been focusing on the expanding global electric-vehicle market.

MEG specializes with companies that have commercial fleets that require by law and government zero emissions mandates to acquire new electric vehicles for their businesses.

Being the "Amazon Platform" for end to end sales & services where enterprises can have full procurement, financing, insurance, batteries and energy along with subsidies for the adoption of electric commercial vehicles.

Over the next 2 years in China more than 24 million commercial vehicles will be required to be replaced with electric vehicles. Ideanomics is well established and strategically positioned to gain a substantial market share of this EV business opportunity.

In Q3 2019, MEG’s China EV unit turned a profit with only 4,172 taxis sold and delivered, only a small fraction of the 1.2 million taxis available for EV adoption.

In August 2019, MEG completed its first sales order of 11,000 e-Taxis for City of Chengdu, China, secured an order in Yunnan Province for 35,000 EV taxis and another order in Guilin, Guanxi Province for 2,300 EV taxis in November 2019.

MEG operates through partnerships with China’s largest automakers, Build Your Dreams (China) (BYD) and Beijing Automotive Industry Co. (BAIC) as well as 24 transportation and 8 financial partners as an end-to-end solutions provider with vehicle procurement, financing, battery charging and energy management needs.

In July 2019, Ideanomics invested in Glory Connection Snd. Bhd, (Glory) a vehicle manufacturer based in Malaysia. Glory holds the only license granted to date for the manufacturing of electric vehicles in Malaysia and is in the process of setting up its manufacturing and assembly capabilities.

Ideanomics’ FinTech division consist of its ownership of the Delaware Board of Trade (DBOT) an Alternative Trading System, Intelligenta a marketing AI solutions company that serves the Financial Services industry and a new FinTech Village, a 58-acre development site in West Hartford, Connecticut.

The fintech business division offers customized services based on best-in-class blockchain, AI and other technologies to mature and emerging businesses across various industries. The company is building a financial technology ecosystem through license agreements, joint ventures and strategic investments, which is referred to as Ideanomics’ “Fintech Ecosystem”.




Share Structure Sept 30, 2019
Market Cap $88,849,138
Outstanding Shares 162,076,044
Restricted Shares 74,424,144
Unrestricted Shares 87,651,900
52 Week Hi-lo $2.84-$0.43



Assets - $164,763,676
Revenues - $ 43,286,378



Institutional Ownership: Fidelity, BlackRock, Vanguard, Charles Schwab, Barclay's Capital


http://www.ideanomics.com/
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 24

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 26

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 35

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

TSA PreCheck Study Reveals Time Savings and Travel Insights

Updated Category News Views 379

Understanding TSA PreCheck's Impact on Travelers The latest survey reveals some interesting insights about TSA PreCheck, especially concerning the time savings that members experience at security checkpoints. Conducted by Upgraded Points, this enlightening study assessed the experience of over 1,500 travelers to evaluate the true advantages of holding a TSA PreCheck...

Continue Reading
Intermap Technologies Enhances Geospatial Solutions with New Offering

Updated Category News Views 217

Intermap Technologies Announces New Prospectus Supplement DENVER – Intermap Technologies Corporation (TSX: IMP; OTCQB: ITMSF), a recognized leader in 3D geospatial products and intelligence solutions, has filed a prospectus supplement in the context of a strategically planned public offering. This initiative signifies a promising step forward, with the company aiming to...

Continue Reading
Urgent Investor Notice: Humacyte Legal Claims Investigation

Updated Category News Views 94

Critical Deadline for Humacyte Investors Approaches As time runs short, investors in Humacyte, Inc. (NASDAQ: HUMA) should pay attention. Faruqi & Faruqi, LLP, a prominent national securities law firm, is actively investigating claims on behalf of investors who have suffered losses exceeding $75,000 due to potential violations in federal securities laws. Understanding Your...

Continue Reading
Empowering Women in Banking: Natalie Bartholomew at Alkami Co:lab

Updated Category News Views 226

Empowering Women in Banking: Natalie Bartholomew at Alkami Co:lab Natalie Bartholomew, a highly recognized advocate for women in financial services, will be the featured speaker for the Women in Banking session at Alkami Co:lab 2026. Her expertise and passion are expected to inspire attendees and foster discussions around women's roles in the financial sector. Alkami...

Continue Reading
Investors Anticipate Strong Earnings from OPAL Fuels Soon

Updated Category News Views 161

OPAL Fuels Earnings Report Insights OPAL Fuels OPAL is preparing to release its quarterly earnings report soon, and investors are keenly interested in the results. As the anticipated date for this report approaches, it is essential for investors to stay informed and understand what the expectations are. Projected Earnings Overview Analysts project that OPAL Fuels will...

Continue Reading